Ballicules.com

Mixed amphetamine salts XR

ADDERALL XR

Mixed amphetamine salts XR ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Mixed amphetamine salts XR ballicule
Mixed amphetamine salts XR ADDERALL mascot mnemonic cartoon
Visual mnemonic: Mixed amphetamine salts XR mascot
“Amp to Add it all”

What it isMixed amphetamine salts XR (ADDERALL XR, 2001) release norepinephrine, dopamine and serotonin for ADHD; approved ages: 6-17, adults.

Why this oneIts 50% IR / 50% DR beads mimic BID coverage for 8-12 h (Carlat Table 1) and are sprinklable.

What limits itAppetite loss, insomnia, tachycardia and blood-pressure rise often limit it. Do not crush; misuse, diversion and dependence remain.

Mixed amphetamine salts XR molecular structure (skeletal formula)
Molecular structure: Mixed amphetamine salts XR

FDA-approved for

FDA label

BOXED WARNING High potential for abuse, misuse, and addiction; can lead to overdose and death.
FDA dosingPopulationStartTargetMax
ADHDAdults20 mg QAM
ADHDPeds 6–12 yr10 mg QAM (may start 5 mg); titrate 5–10 mg/wk30 mg/day
ADHDPeds 13–17 yr10 mg QAM; may increase to 20 mg/day after 1 wk20 mg/day (studied)

Titration Titrate at weekly intervals

Renal Severe renal impairment (GFR 15–<30): adults 15 mg QAM; peds 6–17 yr 5 mg QAM (max 20 mg for 6–12 yr). ESRD (GFR <15): not recommended.

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy May cause premature delivery and low birth weight; monitor neonates for withdrawal.

Lactation Breastfeeding not recommended.

Cost

Mixed amphetamine salts XR (ADDERALL XR)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
5 mgER cap30 qd$14.74not offered
10 mgER cap30 qd$16.18not offered
15 mgER cap30 qd$16.72not offered
20 mgER cap30 qd$17.90not offered
25 mgER cap30 qd$14.68not offered
30 mgER cap30 qd$13.97not offered

Other forms: Amphetamine (ADDERALL) · Mixed amphetamine salts (triple-bead) (MYDAYIS)

⚠ BOXED WARNING

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Serotonin and MAOI

Provisional washout figures

SRI significance0 / 4
MAO-A inhibition0 / 4
Serotonin release1 / 4

Elevating mechanismNone identified

Exposure dependenceNo serotonin-elevating mechanism identified

Evidence confidenceModerate

InterpretationNo clinically meaningful serotonin-elevating mechanism identified in this first-pass Gillman-based review.

Open Mixed amphetamine salts XR in the interactive console ↗

Memory aids: interaction avatars

Mixed amphetamine salts XR weak base avatar mnemonic
weak base

Open Mixed amphetamine salts XR in the interactive console ↗